Headquarters
1123 STANFORD AVE, PALO ALTO, CA 94306-1355, US
PALO ALTO, CA, US
GEN1E LIFESCIENCES INC
From the company
GEn1E Lifesciences is a clinical-stage, Phase 2 company accelerating first-in-class precision therapies for inflammatory and rare diseases. It discovered a new binding pocket and developed a unique, validated mechanism of action for Dual Signal Modulators targeting kinase dysregulation (p38, MK2, ERK). Its GRID AI platform supports its drug development. It received US FDA Orphan Drug and Rare Pediatric Disease designations for a dual signal modulator for Duchenne Muscular Dystrophy.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.